SMTL ID : 4llw.1 (1 other biounit)

Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

hetero-1-1-mer

Ligands

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 8 residues within 4Å: Chain A: Y.39, P.41, G.42, K.43, G.44 Chain B: Y.87, Q.100, K.103 5 PLIP interactions: 2 interactions with chain A, 3 interactions with chain B Hydrogen bonds: A:G.42, A:G.44 Water bridges: B:Y.87, B:Y.87 Salt bridges: B:K.103 SO4.2: 4 residues within 4Å: Chain A: V.72, D.73, R.74, S.75 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:D.73, A:R.74, A:S.75 Salt bridges: A:R.74 SO4.3: 3 residues within 4Å: Chain A: F.27, T.28, Y.32 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.28, A:T.28, A:T.28, A:Y.32, A:Y.32 SO4.4: 3 residues within 4Å: Chain A: H.170 Chain B: S.138, K.172 5 PLIP interactions: 4 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:S.138, B:S.138 Water bridges: B:S.138 Salt bridges: B:K.172, A:H.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lewis, S.M. et al., Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface. Nat.Biotechnol. (2014)

Release Date

2014-01-29

Peptides

mutated Pertuzumab Fab heavy chain: A
light chain Clambda: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

mutated Pertuzumab Fab heavy chain

light chain Clambda

Related Entries With Identical Sequence